BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 11480711)

  • 1. Incidence of cervical carcinoma in the Czech Republic.
    Kobilková J; Pazderník B; Dusková J
    Acta Cytol; 2001; 45(4):515-8. PubMed ID: 11480711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Screening for prevention of cervical cancer in the Czech Republic].
    Tachezy R; Rob L
    Cas Lek Cesk; 2007; 146(12):939-44. PubMed ID: 18257411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical cancer screening in the Czech Republic.
    Tachezy R; Rob L
    Coll Antropol; 2007 Apr; 31 Suppl 2():27-9. PubMed ID: 17598501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Factors which affect cytodiagnosis in gynecology].
    Kobilková J; Lojda Z; Dusková J; Beková A
    Cesk Patol; 2001 Jan; 37(1):10-4. PubMed ID: 11268699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of the Czech National Cervical Cancer screening programme].
    Dušková J; Beková A; Dvořák V; Májek O; Dušek L
    Klin Onkol; 2014; 27 Suppl 2():79-86. PubMed ID: 25494892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Invasive cervical cancer incidence in the span from the preventive check-up to the national screening programing in the Czech Republic].
    Kobilková J; Vinsová R; Dohnalová A; Strunová M
    Ceska Gynekol; 2012 Feb; 77(1):61-6. PubMed ID: 22536643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance indicators in a newly established organized cervical screening programme: registry-based analysis in the Czech Republic.
    Májek O; Dušková J; Dvořák V; Beková A; Klimeš D; Blaha M; Anttila A; Dušek L
    Eur J Cancer Prev; 2017 May; 26(3):232-239. PubMed ID: 26908155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytopathology in Austria.
    Breitenecker G; Dinges HP; Regitnig P; Wiener H; Vutuc Ch
    Cytopathology; 2004 Apr; 15(2):113-8. PubMed ID: 15056173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the effectiveness of cytologic screening for cervical cancer. I. Incidence and mortality trends in relation to screening.
    Dickinson L; Mussey ME; Soule EH; Kurland LT
    Mayo Clin Proc; 1972 Aug; 47(8):534-44. PubMed ID: 5049157
    [No Abstract]   [Full Text] [Related]  

  • 11. The influence of sample takers on the cellular composition of cervical smears.
    Vooijs GP; Elias A; van der Graaf Y; Poelen-van de Berg M
    Acta Cytol; 1986; 30(3):251-7. PubMed ID: 3459325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Knowledge about cervical cancer among respondents in Slovakia and the Czech Republic - Aurora Project].
    Švihrová V; Jílková E; Szabóová V; Baška T; Danko J; Hudečková H
    Ceska Gynekol; 2015 Jun; 80(3):181-8. PubMed ID: 26087212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of cytologic mass screening in the Federal Republic of Germany.
    Soost HJ; Bockmühl B; Zock H
    Acta Cytol; 1982; 26(4):445-52. PubMed ID: 6957096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cancer screening in Canadian Native women. Adequacy of the Papanicolaou smear.
    Hislop TG; Band PR; Deschamps M; Clarke HF; Smith JM; Ng VT
    Acta Cytol; 1994; 38(1):29-32. PubMed ID: 8291352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pap smear screening, pap smear abnormalities and psychosocial risk factors among women in a residential alcohol and drug rehabilitation facility.
    Soccio J; Brown M; Comino E; Friesen E
    J Adv Nurs; 2015 Dec; 71(12):2858-66. PubMed ID: 26279461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical cancer screening programs: summary of the 1982. Canadian task force report.
    Can Med Assoc J; 1982 Oct; 127(7):581-9. PubMed ID: 7127225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer screening in a rural population of Zimbabwe.
    Thistle PJ; Chirenje ZM
    Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus recommendations for cervical cancer prevention in the Czech Republic: a report of the International Conference on Human Papillomavirus in Human Pathology (Prague, 1-3 May 2008).
    Tachezy R; Davies P; Arbyn M; Rob L; Lazdane G; Petrenko J; Hamsíková E; Beková A; Klozar J; Dusková J
    J Med Screen; 2008; 15(4):207-10. PubMed ID: 19106262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of cervical cancer following negative smears in Maribo County, Denmark, 1966-1982.
    Lynge E; Poll P
    IARC Sci Publ; 1986; (76):69-86. PubMed ID: 3570417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of type of screening laboratory on population-based occurrence of cervical lesions in Finland.
    Nieminen P; Hakama M; Tarkkanen J; Anttila A
    Int J Cancer; 2002 Jun; 99(5):732-6. PubMed ID: 12115508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.